Furthermore, PA targets the androgen receptor (AR) to inhibit dihydrotestosterone-induced (DHT)-induced cell proliferation, AR translocation to the nucleus, and downstream gene expression during HCC growth. Here, AR is linked to hepatocellular carcinoma.